FOSINOPRIL SODIUM

Fosinopril Sodium Adverse Events Reported to the FDA Over Time

How are Fosinopril Sodium adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Fosinopril Sodium, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Fosinopril Sodium is flagged as the suspect drug causing the adverse event.

Most Common Fosinopril Sodium Adverse Events Reported to the FDA

What are the most common Fosinopril Sodium adverse events reported to the FDA?

Hyperkalaemia	63 (2.95%)
Renal Failure Acute	61 (2.86%)
Angioedema	36 (1.69%)
Cough	36 (1.69%)
Completed Suicide	33 (1.55%)
Blood Urea Increased	31 (1.45%)
Blood Creatinine Increased	25 (1.17%)
Dizziness	25 (1.17%)
Asthenia	24 (1.13%)
Orthostatic Hypotension	24 (1.13%)
Renal Failure	24 (1.13%)
	Show More
Swelling Face	24 (1.13%)
Abdominal Pain Upper	23 (1.08%)
Hypotension	23 (1.08%)
Syncope	23 (1.08%)
Blood Pressure Increased	22 (1.03%)
Drug Ineffective	22 (1.03%)
Pneumonia	22 (1.03%)
Dyspnoea	21 (.98%)
Nausea	20 (.94%)
Vomiting	20 (.94%)
Pleural Effusion	19 (.89%)
Dehydration	17 (.8%)
Loss Of Consciousness	17 (.8%)
Swollen Tongue	17 (.8%)
Fatigue	16 (.75%)
Hyponatraemia	16 (.75%)
Death	14 (.66%)
Diarrhoea	14 (.66%)
Drug Interaction	14 (.66%)
Pulmonary Congestion	14 (.66%)
Pulmonary Oedema	14 (.66%)
Bundle Branch Block Left	13 (.61%)
Cardiac Arrest	12 (.56%)
Hypertension	12 (.56%)
Lactic Acidosis	12 (.56%)
Renal Impairment	12 (.56%)
Atrial Fibrillation	11 (.52%)
Oedema Peripheral	11 (.52%)
Wheezing	11 (.52%)
Dysphagia	10 (.47%)
Headache	10 (.47%)
Medication Error	10 (.47%)
Renal Disorder	10 (.47%)
Abdominal Pain	9 (.42%)
Blood Glucose Increased	9 (.42%)
Blood Potassium Increased	9 (.42%)
Bradycardia	9 (.42%)
Drug Hypersensitivity	9 (.42%)
Dry Mouth	9 (.42%)
Left Ventricular Failure	9 (.42%)
Pruritus	9 (.42%)
Qrs Axis Abnormal	9 (.42%)
Rash	9 (.42%)
Tachycardia	9 (.42%)
Blood Pressure Inadequately Control...	8 (.38%)
C-reactive Protein Increased	8 (.38%)
Cardiac Failure	8 (.38%)
Failure To Thrive	8 (.38%)
Haemoglobin Decreased	8 (.38%)
Inflammation	8 (.38%)
Malaise	8 (.38%)
Pharyngeal Oedema	8 (.38%)
Pyrexia	8 (.38%)
White Blood Cell Count Decreased	8 (.38%)
Blood Chloride Decreased	7 (.33%)
Blood Cholesterol Increased	7 (.33%)
Blood Potassium Decreased	7 (.33%)
Chest Pain	7 (.33%)
Confusional State	7 (.33%)
Decreased Appetite	7 (.33%)
Hypersensitivity	7 (.33%)
Listless	7 (.33%)
Oedema	7 (.33%)
Pregnancy	7 (.33%)
Prothrombin Time Prolonged	7 (.33%)
Red Blood Cell Count Decreased	7 (.33%)
Vision Blurred	7 (.33%)
Abasia	6 (.28%)
Anaemia	6 (.28%)
Caesarean Section	6 (.28%)
Drug Exposure During Pregnancy	6 (.28%)
Hypocalcaemia	6 (.28%)
Hypokalaemia	6 (.28%)
Hypomagnesaemia	6 (.28%)
Lobar Pneumonia	6 (.28%)
Mental Impairment	6 (.28%)
Metabolic Acidosis	6 (.28%)
Monocyte Count Decreased	6 (.28%)
Neuropathy Peripheral	6 (.28%)
Neutropenia	6 (.28%)
Neutrophil Count Decreased	6 (.28%)
Overdose	6 (.28%)
Pain	6 (.28%)
Respiratory Distress	6 (.28%)
Road Traffic Accident	6 (.28%)
Somnolence	6 (.28%)
Vertigo	6 (.28%)
Aphasia	5 (.23%)
Arteriovenous Fistula Operation	5 (.23%)
Arthralgia	5 (.23%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Fosinopril Sodium, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Fosinopril Sodium is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Fosinopril Sodium

What are the most common Fosinopril Sodium adverse events reported to the FDA?

Renal Disorders	127 (5.96%)
Neurological	116 (5.44%)
Electrolyte And Fluid Balance Condi...	106 (4.97%)
Gastrointestinal Signs	88 (4.13%)
Respiratory	85 (3.99%)
Epidermal And Dermal Conditions	79 (3.71%)
Cardiac Arrhythmias	68 (3.19%)
Renal And Urinary Tract Investigati...	67 (3.14%)
Decreased And Nonspecific Blood Pre...	63 (2.95%)
Hematology Investigations	62 (2.91%)
Therapeutic And Nontherapeutic Effe...	57 (2.67%)
	Show More
Cardiac And Vascular Investigations	46 (2.16%)
Infections - Pathogen Unspecified	46 (2.16%)
Angiedema And Urticaria	42 (1.97%)
Lower Respiratory Tract Disorders	38 (1.78%)
Suicidal And Self-injurious Behavio...	34 (1.59%)
Water, Electrolyte And Mineral	32 (1.5%)
Heart Failures	28 (1.31%)
Medication Errors	26 (1.22%)
Appetite And General Nutritional	25 (1.17%)
Fatal Outcomes	22 (1.03%)
Hepatic And Hepatobiliary	22 (1.03%)
Acid-base	20 (.94%)
Allergic Conditions	20 (.94%)
Gastrointestinal Motility And Defec...	20 (.94%)
Tongue Conditions	20 (.94%)
Pleural	19 (.89%)
Chemical Injury And Poisoning	18 (.84%)
Injuries	17 (.8%)
Metabolic, Nutritional And Blood Ga...	16 (.75%)
Musculoskeletal And Connective Tiss...	16 (.75%)
Headaches	14 (.66%)
Muscle	14 (.66%)
Oral Soft Tissue Conditions	14 (.66%)
Vascular Hypertensive	14 (.66%)
Bronchial Disorders	13 (.61%)
Procedural And Device Related Injur...	13 (.61%)
Bone, Calcium, Magnesium And Phosph...	12 (.56%)
Upper Respiratory Tract Disorders	12 (.56%)
Hepatobiliary	11 (.52%)
Inner Ear And Viiith Cranial Nerve	11 (.52%)
Joint	11 (.52%)
White Blood Cell	11 (.52%)
Anemias Nonhemolytic And Marrow Dep...	10 (.47%)
Body Temperature Conditions	10 (.47%)
Pregnancy, Labour, Delivery And Pos...	10 (.47%)
Salivary Gland Conditions	10 (.47%)
Skin Appendage Conditions	10 (.47%)
Vision	10 (.47%)
Deliria	9 (.42%)
Mental Impairment	9 (.42%)
Mood Disorders	9 (.42%)
Movement Disorders	9 (.42%)
Physical Examination Topics	9 (.42%)
Protein And Chemistry Analyses	9 (.42%)
Urinary Tract Signs	9 (.42%)
Exocrine Pancreas Conditions	8 (.38%)
Eye	8 (.38%)
Lipid Analyses	8 (.38%)
Musculoskeletal And Connective Tiss...	8 (.38%)
Obstetric And Gynecological Therape...	8 (.38%)
Peripheral Neuropathies	8 (.38%)
Bacterial Infectious	7 (.33%)
Central Nervous System Vascular	7 (.33%)
Coronary Artery	6 (.28%)
Disturbances In Thinking	6 (.28%)
Ocular Sensory Symptoms	6 (.28%)
Vascular	6 (.28%)
Gastrointestinal Hemorrhages	5 (.23%)
Respiratory And Mediastinal Neoplas...	5 (.23%)
Skin And Subcutaneous Tissue	5 (.23%)
Toxicology And Therapeutic Drug Mon...	5 (.23%)
Vascular Therapeutic Procedures	5 (.23%)
Administration Site Reactions	4 (.19%)
Anxiety Disorders	4 (.19%)
Cardiac Disorder Signs	4 (.19%)
Congenital And Hereditary	4 (.19%)
Eating Disorders	4 (.19%)
Embolism And Thrombosis	4 (.19%)
Encephalopathies	4 (.19%)
Hematological And Lymphoid Tissue T...	4 (.19%)
Neuromuscular	4 (.19%)
Product Quality Issues	4 (.19%)
Respiratory Tract Therapeutic Proce...	4 (.19%)
Sleep Disorders	4 (.19%)
Arteriosclerosis, Stenosis, Vascula...	3 (.14%)
Bone And Joint Injuries	3 (.14%)
Depressed Mood Disorders	3 (.14%)
Fetal Complications	3 (.14%)
Gastrointestinal Therapeutic Proced...	3 (.14%)
Glucose Metabolism Disorders	3 (.14%)
Hearing	3 (.14%)
Leukemias	3 (.14%)
Lifestyle Issues	3 (.14%)
Maternal Complications Of Pregnancy	3 (.14%)
Ocular Infections, Irritations And ...	3 (.14%)
Penile And Scrotal Disorders	3 (.14%)
Peritoneal And Retroperitoneal Cond...	3 (.14%)
Placental, Amniotic And Cavity Diso...	3 (.14%)
Platelet	3 (.14%)
Renal And Urinary Tract Disorders C...	3 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Fosinopril Sodium, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Fosinopril Sodium is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.